Pfizer’s ex-R&D chief Dolsten withdraws from Novo Nordisk board race
(Reuters) -Mikael Dolsten, Pfizer's former research and development chief, has withdrawn his candidacy for Novo Nordisk's board, citing personal reasons, ...
Monday, January 19, 2026
Tag: Pfizers
Key takeaways from Pfizer’s (PFE) Q3 2025 earnings report
Shares of Pfizer Inc. (NYSE: PFE) stayed green during midday trade on Tuesday following the company’s announcement of its third ...
The first and only national digital and print magazine that connects individuals, families, and businesses to Fee-Only financial advisers, accountants, attorneys and college guidance counselors.